Sort
23,748 grants matching “melanoma”
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$227,240Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2013 · CA
CONTROL OF DENDRITIC CELL GENERATION &FUNCTION BY TUMOR
$227,217University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
Role of CD44 in EC injury and melanoma therapy
$227,200Mitzi Nagarkatti · University Of South Carolina At Columbia · R01 · FY2006 · AI
ANTI-NEOPLASTIC EFFECTS OF GAMMA-SECRETASE INHIBITORS
$227,186Lucio Miele · University Of Massachusetts Amherst · P01 · FY2007 · AG
CORE--Biostatistics & Data Management
$227,173Janiel M Shields · Univ Of North Carolina Chapel Hill · P01 · FY2009 · ES
MACROPHAGE-CENTRIC PROGNOSTIC BIOMARKERS FOR CHECKPOINT BLOCKADE IMMUNOTHERAPY IN MELANOMA
$227,167University Of Alabama At Birmingham · · FY2025 · Defense Health Agency
Metabolic Engineering of Cancer for Selective Immunotargeting (NIH/NCI: 5R01CA095142-14)
$227,124Zhongwu Guo · University Of Florida · R01 · FY2019 · CA
Melanoma vaccines
$227,117Karl Erik Hellstrom · University Of Washington · R01 · FY2007 · CA
Development of next-generation cancer functional diagnostics
$227,070David E Fisher · Massachusetts General Hospital · R21 · FY2013 · CA
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
$227,059Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
KiSS1 treatment of pancreatic adenocarcinoma
$227,040Lacey R McNally · University Of Louisville · R00 · FY2013 · CA
COLLAGEN STRUCTURAL MODULATION OF TUMOR BEHAVIORS
$226,996Florida Atlantic University · R01 · FY2002 · CA
Inhibitors of p53-S100B interaction for melanoma
$226,982David Maloney · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Identification of Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
$226,982Matthew Boxer · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
'Arresting' bone marrow T cell sequestration in patients with GBM
$226,874Peter Fecci · Duke University · P50 · FY2022 · CA
Inhibition of the host cell AIM2 inflammasome by Mycobacterium tuberculosis
$226,854Volker Briken · Univ Of Maryland, College Park · R21 · FY2014 · AI
Targeted immunotherapy of breast cancer with central memory T cells
$226,803Stanley R Riddell · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
SIGNALING MECHANISMS FOR WNT PROTEINS
$226,755University Of Connecticut Sch Of Med/Dnt · R01 · FY2003 · CA
Generation and Repair of an Unusual UV Photoproduct
$226,660Montana State University (Bozeman) · R01 · FY2005 · GM
Intestinal NOD2 and the microbiota enhance Coxsackievirus B3 pathogenesis
$226,641Arina Marijke Keestra-Gounder · University Of Colorado Denver · R21 · FY2025 · AI
PILOT STUDIES
$226,574Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2009 · CA
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA
$226,517Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$226,500Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2014 · CA
Smad3 inhibitors for ophthalmic applications
$226,500Ching Yuan · University Of Minnesota · R21 · FY2010 · EY
Optimization of Tannic Acid Lipid Nanoparticles for a Therapeutic mRNA Vaccine Against Melanoma
$226,495Owen S Fenton · Univ Of North Carolina Chapel Hill · R21 · FY2023 · EB